Randy Levitt, PhD

Randy Levitt is responsible for pharmacovigilance and medical affairs activities at Paladin. He is also the local compliance champion and works with the international compliance team at Endo, the parent company of Paladin. He joined Paladin in 2011 as Manager, Scientific Communications and Publications after Paladin’s acquisition of Labopharm, where he had worked in the medical department since 2008. Randy completed his undergraduate and graduate degrees at McGill University, graduating with his PhD in Experimental Medicine in 2006.